PATIENT FOCUSSED

DRUG DEVELOPMENT

Ensuring the SCI community's voice is heard.

The first-ever Patient-Focused Drug Development (PFDD) meeting dedicated to spinal cord injury will take place on September 29, 2026. This historic meeting is an opportunity for people living with SCI, families, caregivers, and advocates to share their experiences and help inform the future of treatment evaluation.

BreakThru SCI is proud to support this effort as a member of the PFDD Steering Committee. Every voice matters. Every story matters.